SS Innovations International Inc (SSII) USD0.0001

Sell:$5.30Buy:$6.00$0.58 (12.21%)

Prices delayed by at least 15 minutes
Sell:$5.30
Buy:$6.00
Change:$0.58 (12.21%)
Prices delayed by at least 15 minutes
Sell:$5.30
Buy:$6.00
Change:$0.58 (12.21%)
Prices delayed by at least 15 minutes

Company Information

About this company

SS Innovations International, Inc. is a developer of surgical robotic technologies. The Company’s product range includes its proprietary SSi Mantra surgical robotic system and its comprehensive suite of SSi Mudra surgical instruments, which support a variety of surgical procedures including robotic cardiac surgery. The SSi Mantra Surgical Robotic System is designed to enable surgeons to perform a wide range of surgical procedures including cardiovascular, thoracic, head and neck, gynecological, urological, cancer and general surgeries. The SSi Mantra 3 is comprised of components, such as Surgeon Console, Patient-Side Robotic Arm Carts, and Vision Cart. Its instruments under development include NADI-Automated Coronary Anastomotic Connector, SSi Multi-Fire Clip Applier, SSi Ultrasonic Surgical Device, SSi Maya-XR Pre-Operative Simulator, SSi Holographic Anatomy, SSi Yog-Tele Proctor, SSi Chitrasa-Advanced DICOM Viewer and SSi Mixed Reality Headset.

Key people

Sudhir Srivastava
Chairman of the Board, Chief Executive Officer
Arvind Palaniappan
Interim Chief Financial Officer
Vishwajyoti P. Srivastava
Chief Executive Officer, Asia Pacific, Director
Barry F. Cohen
Chief Operating Officer, Americas, Director
Tim Adams
Independent Director
Mylswamy Annadurai
Independent Director
Frederic H. Moll
Independent Director
S.P. Somashekhar
Independent Director
Click to see more

Key facts

  • EPIC
    SSII
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • ISIN
    US05453U2033
  • Market cap
    $966.08m
  • Employees
    378
  • Shares in issue
    193.60m
  • Exchange
    NASDAQ
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.